EC Clinical and Medical Case Reports

Moya Moya disease (MMM) is a chronic cerebral artery condition of unknown cause, identified by the narrowing and blockage of the end sections of the intracranial internal carotid arteries and the proximal arteries of the circle of Willis, leading to the development of a fine, abnormal compensatory vascular network. This disease affects both children and young adults, often causing strokes in children. Imaging is critical for diagnosis, treatment planning, and monitoring. Angiography is the primary diagnostic tool, while non-invasive, non-irradiating MRI plays a key role in disease monitoring. Surgical revascularization techniques have shown promise in improving cerebral blood flow.

 Keywords: Moya-Moya Disease; Stroke; Imaging

1. NM Wetjen., et al. “Moyamoya disease in the mid western United States”. Clinical Neurology and Neurosurgery2 (1997): S31-S35.
2. N Khan., et al. “Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures”. Acta Neurochirurgica12 (2003): 1061-1071.
3. Y Natori., et al. ““Angiographic Moyamoya” its definition, classification, and therapy”. Clinical Neurology and Neurosurgery2 (1997): S168-S172.
4. O'Gorman., et al. “Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease”. Pediatric Neurology3 (1996): 226-230.
5. J Lutterman., et al. “Moyamoya syndrome associated with congenital heart disease”. Pediatrics1 (1998): 57-60.
6. ER Smith and RM Scott. “Moyamoya syndrome associated with congenital heart disease”. Skull Base1 (2005): 15-26.
7. SW Atlas. “MR Angiography: Techniques and Clinical Applications MRI of the Brain and Spine”. Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 3^rd edition (2002).
8. Smith ER and Scott RM. “Surgical management of moyamoya syndrome”. Skull Base1 (2005): 15-26.
9. Smith JL. “Understanding and treating moyamoya disease in children”. Neurosurgery Focus4 (2009): E4.
10. Scott RM and Smith ER. “Moyamoya disease and moyamoya syndrome”. New England Journal of Medicine12 (2009): 1226-1237.
11. Kawaguchi S., et al. “Characteristics of intracranial aneurysms associated with moyamoya disease: a review of 111 cases”. Acta Neurochirurgica (Wein)11 (1996): 1287-1294.
12. Nakashima T., et al. “Arteriovenous malformation in association with moyamoya disease. Report of two cases”. Neurosurgery Focus5 (1998): e6.
13. Kikuchi M., et al. “Evaluation of surgically formed collateral circulation in moyamoya disease with 3D-CT angiography: comparison with MR angiography and X-ray angiography”. Neuropediatrics 1 (1996): 45-49.
14. Chabbert V., et al. “Diffusion- and magnetization transfer-weighted MRI in childhood moya-moya”. Neuroradiology 4 (1998): 267-271.
15. Scott RM and Smith ER. “Moyamoya disease and moyamoya syndrome”. New England Journal of Medicine 12 (2009): 1226-1237.
16. Fujiwara H., et al. “Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion recovery (FLAIR) MR images in moyamoya disease”. European Journal of Radiology 2 (2005): 224-2307.
17. Yamada I., et al. “Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography”. Radiology1 (1995): 211-218.
18. Yamada I., et al. “Moyamoya disease: diagnosis with three-dimensional time-of-flight MR angiography”. Radiology 3 (1992): 773-778.
19. Pandey P and Steinberg GK. “Neurosurgical advances in the treatment of moyamoya disease”. Stroke 11 (2011): 3304-3310.
20. Arias EJ., et al. “Advances and surgical considerations in the treatment of moyamoya disease”. Neurosurgery 1 (2014): S116-S125.